MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (HTFL), the leader in AI technology for coronary artery disease (CAD), announced two new analyses from FISH&CHIPS, a real-world ...
MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...
MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology (ACC) and ...
The MarketWatch News Department was not involved in the creation of this content. MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary ...
The cardiac health specialist announced FDA approval for one of its diagnostic products. It didn't hesitate to say the HeartFlow Plaque Analysis is now available for purchase. HeartFlow's ...
HeartFlow (NasdaqGS:HTFL) is expanding its GAMEFILM Registry to include retired NBA and NHL athletes. The program focuses on heart health in professional sports, using AI based heart disease ...
Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results